| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV-CELLBIO-092910-154002 |
| P953 | full work available at URL | http://arjournals.annualreviews.org/doi/abs/10.1146/annurev-cellbio-092910-154002 |
| P698 | PubMed publication ID | 21756109 |
| P50 | author | Napoleone Ferrara | Q1769254 |
| P2093 | author name string | Alicia S. Chung | |
| P2860 | cites work | Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall | Q35967045 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| P304 | page(s) | 563-584 | |
| P577 | publication date | 2011-07-13 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Annual Review of Cell and Developmental Biology | Q4497277 |
| P1476 | title | Developmental and pathological angiogenesis | |
| P478 | volume | 27 |
| Q54982188 | A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis. |
| Q64263430 | A PKA/cdc42 Signaling Axis Restricts Angiogenic Sprouting by Regulating Podosome Rosette Biogenesis and Matrix Remodeling |
| Q36415707 | A Role for Virally Induced Reactive Oxygen Species in Kaposi's Sarcoma Herpesvirus Tumorigenesis |
| Q37157371 | A VEGF-dependent gene signature enriched in mesenchymal ovarian cancer predicts patient prognosis. |
| Q38074494 | A brief primer on microRNAs and their roles in angiogenesis |
| Q90739896 | A combined hiPSC-derived endothelial cell and in vitro microfluidic platform for assessing biomaterial-based angiogenesis |
| Q27324767 | A computational model predicting disruption of blood vessel development |
| Q35661239 | A coupled model of neovessel growth and matrix mechanics describes and predicts angiogenesis in vitro |
| Q89637920 | A negative-feedback loop maintains optimal chemokine concentrations for directional cell migration |
| Q29347063 | A novel role for syndecan-3 in angiogenesis |
| Q38888721 | AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling. |
| Q100416095 | Ablation of neuropilin-1 improves the therapeutic response in conventional drug-resistant glioblastoma multiforme |
| Q38862195 | Acceleration of Lung Regeneration by Platelet-Rich Plasma Extract through the Low-Density Lipoprotein Receptor-Related Protein 5-Tie2 Pathway |
| Q38425671 | Actin-tethered junctional complexes in angiogenesis and lymphangiogenesis in association with vascular endothelial growth factor. |
| Q37352210 | Adipose tissue angiogenesis: Impact on obesity and type-2 diabetes |
| Q36388931 | Advanced targeted nanomedicine |
| Q47073300 | AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion |
| Q38870684 | Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells |
| Q36187754 | An integrated approach to quantitative modelling in angiogenesis research |
| Q36959804 | Angiogenesis in Liquid Tumors: An In Vitro Assay for Leukemic-Cell-Induced Bone Marrow Angiogenesis. |
| Q51303378 | Angiogenic Potential of Multipotent Stromal Cells from the Umbilical Cord: an In Vitro Study |
| Q37281639 | Angiogenic neovessels promote tissue hypoxia |
| Q37958946 | Angiogenic properties of the chemokine RANTES/CCL5 |
| Q30832184 | Angiopoietin 2 signaling plays a critical role in neural crest cell migration |
| Q90215399 | Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema |
| Q35814050 | Anti-Angiogenic Properties of BDDPM, a Bromophenol from Marine Red Alga Rhodomela confervoides, with Multi Receptor Tyrosine Kinase Inhibition Effects |
| Q38109457 | Anti-angiogenesis in cancer therapy: Hercules and hydra |
| Q51317921 | Antiangiogenic Therapeutic Potential of Peptides Derived from the Molecular Motor KIF13B that Transports VEGFR2 to Plasmalemma in Endothelial Cells |
| Q37446015 | Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme |
| Q50993734 | Assessment of MiRNA Regulation of Endothelial Progenitor Cell Mediated Angiogenesis |
| Q35995721 | Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma |
| Q54759427 | Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis. |
| Q90051333 | BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression |
| Q34326101 | BAMBI regulates angiogenesis and endothelial homeostasis through modulation of alternative TGFβ signaling |
| Q37702378 | Baicalein reduces angiogenesis in the inflammatory microenvironment via inhibiting the expression of AP-1. |
| Q89582435 | Beta secretase 1-dependent amyloid precursor protein processing promotes excessive vascular sprouting through NOTCH3 signalling |
| Q46222214 | Betaglycan knock-down causes embryonic angiogenesis defects in zebrafish |
| Q50146924 | Biology of Bone: The Vasculature of the Skeletal System |
| Q34124396 | Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming |
| Q46433721 | Blood vessel formation during tail regeneration in the leopard gecko (Eublepharis macularius): The blastema is not avascular. |
| Q37635341 | Borg5 is required for angiogenesis by regulating persistent directional migration of the cardiac microvascular endothelial cells |
| Q37660089 | C1q as a unique player in angiogenesis with therapeutic implication in wound healing |
| Q37612276 | CD133+ cancer stem cells promoted by VEGF accelerate the recurrence of hepatocellular carcinoma |
| Q35146217 | CD146 acts as a novel receptor for netrin-1 in promoting angiogenesis and vascular development. |
| Q36063268 | CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy |
| Q22242276 | Cancer genome landscapes |
| Q36974857 | CdGAP/ARHGAP31, a Cdc42/Rac1 GTPase regulator, is critical for vascular development and VEGF-mediated angiogenesis. |
| Q90333636 | Cell-Cell Communication Breakdown and Endothelial Dysfunction |
| Q37662235 | Cell-permeable iron inhibits vascular endothelial growth factor receptor-2 signaling and tumor angiogenesis |
| Q37240221 | Chronic effects of an anti-angiogenic thrombospondin-1 mimetic peptide, ABT-898, on female mouse reproductive outcomes |
| Q50664793 | Cited2 is required in trophoblasts for correct placental capillary patterning |
| Q60050019 | Co-treatment of tumor cells with hyaluronan plus doxorubicin affects endothelial cell behavior independently of VEGF expression |
| Q57456667 | Combination therapy to checkmate Glioblastoma: clinical challenges and advances |
| Q40628016 | Combined effects of age and polymorphisms in Notch3 in the pathogenesis of cerebral infarction disease |
| Q92513343 | Comparison of the ligand-binding properties of fluorescent VEGF-A isoforms to VEGF receptor 2 in living cells and membrane preparations using NanoBRET |
| Q35219893 | Compatibility of a novel thrombospondin-1 analog with fertility and pregnancy in a xenograft mouse model of endometriosis |
| Q31120422 | Contrasting roles of E2F2 and E2F3 in cardiac neovascularization |
| Q47340134 | Control of endothelial cell tube formation by Notch ligand intracellular domain interactions with activator protein 1 (AP-1). |
| Q47964831 | Critical role of caveolin-1 in ocular neovascularization and multitargeted antiangiogenic effects of cavtratin via JNK. |
| Q36363863 | Critical roles for murine Reck in the regulation of vascular patterning and stabilization |
| Q42378361 | Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration |
| Q37457484 | Dendritic cell-derived VEGF-A plays a role in inflammatory angiogenesis of human secondary lymphoid organs and is driven by the coordinated activation of multiple transcription factors |
| Q39027251 | Dental pulp tissue engineering with bFGF-incorporated silk fibroin scaffolds. |
| Q27004391 | Developments in purification methods for obtaining and evaluation of collagen derived endogenous angioinhibitors |
| Q64997947 | Devitalized Stem Cell Microsheets for Sustainable Release of Osteogenic and Vasculogenic Growth Factors and Regulation of Anti-Inflammatory Immune Response. |
| Q39321185 | Dialysis-related transcriptomic profiling: the pivotal role of heparanase |
| Q91003903 | Didymin by suppressing NF-κB activation prevents VEGF-induced angiogenesis in vitro and in vivo |
| Q37388064 | Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors |
| Q36340825 | Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma |
| Q37978259 | Disruption of embryonic vascular development in predictive toxicology |
| Q44244521 | Driving developmental and evolutionary change: A systems biology view |
| Q88869497 | ER stress and unfolded protein response in ocular health and disease |
| Q93125378 | Effects of age-dependent changes in cell size on endothelial cell proliferation and senescence through YAP1 |
| Q38958610 | Effects of p75 neurotrophin receptor on regulating hypoxia-induced angiogenic factors in retinal pigment epithelial cells |
| Q38625028 | Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis |
| Q30646148 | Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium |
| Q38773099 | Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences. |
| Q64900172 | Emerging Roles of Redox-Mediated Angiogenesis and Oxidative Stress in Dermatoses. |
| Q26801642 | Emerging and Novel Functions of Complement Protein C1q |
| Q92577522 | Endothelial RhoA GTPase is essential for in vitro endothelial functions but dispensable for physiological in vivo angiogenesis |
| Q89620105 | Endothelial Transient Receptor Potential Channels and Vascular Remodeling: Extracellular Ca2 + Entry for Angiogenesis, Arteriogenesis and Vasculogenesis |
| Q34218313 | Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. |
| Q39133326 | Endothelial cell markers from clinician's perspective. |
| Q34228247 | Endothelial cell metabolism: parallels and divergences with cancer cell metabolism |
| Q35255024 | Endothelial cell tube formation assay for the in vitro study of angiogenesis |
| Q30413823 | Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia. |
| Q55394119 | Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury. |
| Q55378702 | Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology. |
| Q47987289 | Enhanced VEGF signalling mediates cerebral neovascularisation via downregulation of guidance protein ROBO4 in a rat model of diabetes |
| Q38794591 | Enhanced peripheral dopamine impairs post-ischemic healing by suppressing angiotensin receptor type 1 expression in endothelial cells and inhibiting angiogenesis. |
| Q51321047 | Exosomes in Tumor Angiogenesis |
| Q34804564 | Expression of Vimentin Intermediate Filament for Vascular Development in Olive Flounder (Paralichthys olivaceus). |
| Q49722001 | Extracellular Lactate Dehydrogenase A Release From Damaged Neurons Drives Central Nervous System Angiogenesis |
| Q27000351 | Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning. |
| Q58590572 | Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy |
| Q47174627 | G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts |
| Q33779141 | Galectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGF |
| Q36997157 | Gene expression changes in aging retinal microglia: relationship to microglial support functions and regulation of activation |
| Q38618997 | Gene transfer by pulsed electric field is highly promising in cutaneous wound healing. |
| Q35023052 | Genetic targeting of sprouting angiogenesis using Apln-CreER. |
| Q26765854 | Glioma Stem Cells: Signaling, Microenvironment, and Therapy |
| Q50594098 | Glipizide suppresses embryonic vasculogenesis and angiogenesis through targeting natriuretic peptide receptor A. |
| Q30559574 | Glutaredoxin regulates vascular development by reversible glutathionylation of sirtuin 1. |
| Q24337334 | Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors |
| Q38216381 | Graft microvascular disease in solid organ transplantation |
| Q50420905 | Granulin Secreted by the Food-Borne Liver Fluke Opisthorchis viverrini Promotes Angiogenesis in Human Endothelial Cells |
| Q28072132 | Heading in the Right Direction: Understanding Cellular Orientation Responses to Complex Biophysical Environments |
| Q55418390 | Hesperidin, a plant flavonoid accelerated the cutaneous wound healing in streptozotocin-induced diabetic rats: Role of TGF-ß/Smads and Ang-1/Tie-2 signaling pathways. |
| Q41777022 | Human colorectal cancer cells induce vascular smooth muscle cell apoptosis in an exocrine manner |
| Q93129624 | Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells |
| Q51063080 | Identification of RUNX1 as a Mediator of Aberrant Retinal Angiogenesis |
| Q37626064 | Imaging aspects of the tumor stroma with therapeutic implications |
| Q53136378 | Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis |
| Q37033252 | Inducers of Hypoxic Response: Marine Sesquiterpene Quinones Activate HIF-1 |
| Q36565126 | Induction of WNT11 by hypoxia and hypoxia-inducible factor-1α regulates cell proliferation, migration and invasion |
| Q38083584 | Inflammation and oxidative stress in angiogenesis and vascular disease. |
| Q36258054 | Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1. |
| Q58767234 | Inhibition of retinal angiogenesis by gold nanoparticles inducing autophagy |
| Q24338659 | Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties |
| Q47142887 | Inhibitory effect of caveolin-1 in vascular endothelial cells, pericytes and smooth muscle cells |
| Q41094823 | Interleukin 37 promotes angiogenesis through TGF-β signaling |
| Q37059771 | Intracellular and Extracellular miRNAs in Regulation of Angiogenesis Signaling |
| Q35446009 | Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses |
| Q48330378 | Isolation and screening of proangiogenic and antiangiogenic metabolites producing rare actinobacteria from soil. |
| Q28508560 | LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling. |
| Q61450972 | LRP5 in age-related changes in vascular and alveolar morphogenesis in the lung |
| Q49952435 | LTBP3 promotes early metastatic events during cancer cell dissemination |
| Q37723648 | Laminar and temporal expression dynamics of coding and noncoding RNAs in the mouse neocortex |
| Q38932870 | Lipocalin2 as a plasma marker for tumors with hypoxic regions. |
| Q41899475 | Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration |
| Q50960970 | Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway |
| Q38190359 | Lymphangiogenesis and lymphatic vessel remodelling in cancer |
| Q61796273 | Macrophages restrict the nephrogenic field and promote endothelial connections during kidney development |
| Q38366707 | Mechanism and Function of Angiogenin in Hematopoietic Malignancy |
| Q38909541 | Mechanisms and regulation of endothelial VEGF receptor signalling. |
| Q35162521 | Mechanisms governing metastatic dormancy and reactivation |
| Q24310981 | MicroRNA 329 Suppresses Angiogenesis by Targeting CD146 |
| Q90655336 | MicroRNA-126-3p Inhibits Angiogenic Function of Human Lung Microvascular Endothelial Cell via LAT1 (L-Type Amino Acid Transporter 1)-Mediated mTOR (Mammalian Target of Rapamycin) Signaling |
| Q64243138 | Micrornas at the Interface between Osteogenesis and Angiogenesis as Targets for Bone Regeneration |
| Q47598622 | Modeling angiogenesis with micro- and nanotechnology |
| Q39020269 | Modulation of VEGF receptor 2 signaling by protein phosphatases |
| Q38226097 | Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies. |
| Q36220942 | Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach |
| Q27003898 | Mouse models for studying angiogenesis and lymphangiogenesis in cancer |
| Q36432462 | NAADP-Dependent Ca(2+) Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis |
| Q36414332 | NCOA1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription |
| Q98280988 | NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function |
| Q41762927 | Need glucose to sprout: local metabolic control of angiogenesis |
| Q38268456 | Neuropilin regulation of angiogenesis |
| Q38187496 | Neuropilin regulation of angiogenesis, arteriogenesis, and vascular permeability |
| Q34340832 | Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding |
| Q38805816 | Notch signaling in regulating angiogenesis in a 3D biomimetic environment |
| Q46817102 | Overexpression of vascular endothelial growth factor in the germinal matrix induces neurovascular proteases and intraventricular hemorrhage. |
| Q26799981 | Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid |
| Q38684978 | Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma. |
| Q39095124 | Oxidative Stress and Carcinogenesis: Potential of Phytochemicals in Breast Cancer Therapy. |
| Q37535220 | Oxidative stress in angiogenesis and vascular disease |
| Q60957157 | Oxidative stress, autophagy and pyroptosis in the neovascularization of oxygen‑induced retinopathy in mice |
| Q83518487 | Partners in crime: VEGF and IL‐4 conscript tumour‐promoting macrophages |
| Q27023951 | Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization |
| Q37702693 | Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression |
| Q46676600 | Pharmacologic characterization of a kinetic in vitro human co-culture angiogenesis model using clinically relevant compounds |
| Q46574147 | Phosphoproteomic analysis implicates the mTORC2-FoxO1 axis in VEGF signaling and feedback activation of receptor tyrosine kinases |
| Q37059810 | Plants and their active compounds: natural molecules to target angiogenesis |
| Q42438243 | Platelet rich plasma extract promotes angiogenesis through the angiopoietin1-Tie2 pathway |
| Q34388847 | Practicing pathology in the era of big data and personalized medicine |
| Q41961687 | Pregnancy-specific glycoprotein 9 (PSG9), a driver for colorectal cancer, enhances angiogenesis via activation of SMAD4. |
| Q47953629 | Progesterone-mediated angiogenic activity of endothelial progenitor cell and angiogenesis in traumatic brain injury rats were antagonized by progesterone receptor antagonist. |
| Q34345914 | Prostate specific membrane antigen (PSMA) regulates angiogenesis independently of VEGF during ocular neovascularization. |
| Q36640864 | Pseudotyped retroviruses for infecting axolotl in vivo and in vitro. |
| Q99592168 | REC8 suppresses tumor angiogenesis by inhibition of NF-κB-mediated vascular endothelial growth factor expression in gastric cancer cells |
| Q37334741 | Rasip1 regulates vertebrate vascular endothelial junction stability through Epac1-Rap1 signaling |
| Q58724518 | Real-Time Ligand Binding of Fluorescent VEGF-A Isoforms that Discriminate between VEGFR2 and NRP1 in Living Cells |
| Q38125964 | Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer |
| Q90466813 | Redox basis of exercise physiology |
| Q40455945 | Regulation of vascular endothelial junction stability and remodeling through Rap1-Rasip1 signaling |
| Q52579664 | Requisite endothelial reactivation and effective siRNA nanoparticle targeting of Etv2/Er71 in tumor angiogenesis |
| Q40300781 | Retinoic Acid Inducible Gene 1 Protein (RIG1)-Like Receptor Pathway Is Required for Efficient Nuclear Reprogramming |
| Q26765484 | Review on a Traditional Herbal Medicine, Eurycoma longifolia Jack (Tongkat Ali): Its Traditional Uses, Chemistry, Evidence-Based Pharmacology and Toxicology |
| Q38042884 | Robustness of the hypoxic response: another job for miRNAs? |
| Q64058497 | Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis |
| Q51711774 | Role of Twist1 Phosphorylation in Angiogenesis and Pulmonary Fibrosis |
| Q92560341 | Roles of HIFs and VEGF in angiogenesis in the retina and brain |
| Q36085802 | SWI/SNF chromatin-remodeling enzymes Brahma-related gene 1 (BRG1) and Brahma (BRM) are dispensable in multiple models of postnatal angiogenesis but are required for vascular integrity in infant mice |
| Q39070835 | Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. |
| Q36159455 | Semaphorin-3C signals through Neuropilin-1 and PlexinD1 receptors to inhibit pathological angiogenesis. |
| Q35954103 | Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer |
| Q41455499 | Silencing Of Circular RNA-ZNF609 Ameliorates Vascular Endothelial Dysfunction |
| Q27342874 | Single-cell analysis of endothelial morphogenesis in vivo |
| Q39102302 | Site-Specific N-Glycosylation of Endothelial Cell Receptor Tyrosine Kinase VEGFR-2. |
| Q37180614 | SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis |
| Q55196550 | Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface. |
| Q40281857 | Soluble FLT1 Gene Therapy Alleviates Brain Arteriovenous Malformation Severity |
| Q36497233 | Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice |
| Q89720871 | Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization |
| Q91877735 | Sphingosine-1-Phosphate Receptor 1 Activity Promotes Tumor Growth by Amplifying VEGF-VEGFR2 Angiogenic Signaling |
| Q33620110 | Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization. |
| Q35228265 | Swimming-induced exercise promotes hypertrophy and vascularization of fast skeletal muscle fibres and activation of myogenic and angiogenic transcriptional programs in adult zebrafish |
| Q35783198 | Synergistic Binding of Vascular Endothelial Growth Factor-A and Its Receptors to Heparin Selectively Modulates Complex Affinity |
| Q37298327 | Systemic Administration of Exosomes Released from Mesenchymal Stromal Cells Promote Functional Recovery and Neurovascular Plasticity After Stroke in Rats |
| Q89586015 | Systems Modeling of Developmental Vascular Toxicity |
| Q49986509 | TSLP promotes angiogenesis of human umbilical vein endothelial cells by strengthening the crosstalk between cervical cancer cells and eosinophils |
| Q38592520 | Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective |
| Q35055518 | Targeted identification of sialoglycoproteins in hypoxic endothelial cells and validation in zebrafish reveal roles for proteins in angiogenesis |
| Q64253749 | Targeting Tyrosine kinases in Renal Cell Carcinoma: "New Bullets against Old Guys" |
| Q55008337 | Targeting VEGF/VEGFR to Modulate Antitumor Immunity. |
| Q39084331 | Targeting endothelial metabolism for anti-angiogenesis therapy: A pharmacological perspective |
| Q91996847 | Temporal VEGFA responsive genes in HUVECs: Gene signatures and potential ligands/receptors fine-tuning angiogenesis |
| Q95853629 | The Anticancer and Anti-inflammatory Effects of Centaurea solstitialis Extract on Human Cancer Cell Lines |
| Q33765926 | The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy |
| Q50107402 | The Effects of Isopropyl Methylphosphono-Fluoridate (IMPF) Poisoning on Tumor Growth and Angiogenesis in BALB/C Mice |
| Q36753726 | The Eyes Absent Proteins in Developmental and Pathological Angiogenesis |
| Q36597900 | The Eyes Absent proteins in development and disease |
| Q50099967 | The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular endothelial growth factor receptor-2 (VEGFR2)-dependent signaling |
| Q37996222 | The Role of Avastin in the Management of Recurrent Glioblastoma |
| Q28077024 | The Role of CC-Chemokines in the Regulation of Angiogenesis |
| Q64958395 | The Role of Dll4/Notch Signaling in Normal and Pathological Ocular Angiogenesis: Dll4 Controls Blood Vessel Sprouting and Vessel Remodeling in Normal and Pathological Conditions. |
| Q54445158 | The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response |
| Q94596270 | The Role of Rho GTPases in VEGF Signaling in Cancer Cells |
| Q91742138 | The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry |
| Q92156470 | The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy |
| Q27321847 | The alternative splicing factor Nova2 regulates vascular development and lumen formation |
| Q38917878 | The anti-angiogenic and cytotoxic effects of the boswellic acid analog BA145 are potentiated by autophagy inhibitors |
| Q28067149 | The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review) |
| Q39131192 | The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. |
| Q37987661 | The biology of personalized cancer medicine: Facing individual complexities underlying hallmark capabilities |
| Q38901012 | The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination |
| Q26771483 | The immunological effect of hyaluronan in tumor angiogenesis |
| Q39032998 | The marine fungal metabolite, AD0157, inhibits angiogenesis by targeting the Akt signaling pathway |
| Q47865822 | The mechanism and potential targets of class II HDACs in angiogenesis |
| Q39127982 | The molecular basis of endothelial cell plasticity. |
| Q24339531 | The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis |
| Q39018218 | The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes |
| Q48098509 | The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma. |
| Q132730851 | The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2- and TAZ-signaling |
| Q132730895 | The regulation of yes-associated protein/transcriptional coactivator with PDZ-binding motif and their roles in vascular endothelium |
| Q37683553 | The role IL-1 in tumor-mediated angiogenesis |
| Q28068373 | The role of integrins in TGFβ activation in the tumour stroma |
| Q47729622 | The role of tumor angiogenesis as a therapeutic target in colorectal cancer |
| Q26852080 | The unfolded protein response in retinal vascular diseases: implications and therapeutic potential beyond protein folding |
| Q47559296 | Three-dimensional Reconstruction of the Vascular Architecture of the Passive CLARITY-cleared Mouse Ovary |
| Q37719815 | Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study |
| Q37524215 | Tie1 deletion inhibits tumor growth and improves angiopoietin antagonist therapy |
| Q42370083 | Tortuous Microvessels Contribute to Wound Healing via Sprouting Angiogenesis |
| Q55177521 | Transforming Growth Factor-β Signaling Plays a Pivotal Role in the Interplay Between Osteosarcoma Cells and Their Microenvironment. |
| Q47616016 | Tumor Microvessel Density as a Potential Predictive Marker for Bevacizumab Benefit: GOG-0218 Biomarker Analyses |
| Q37364878 | Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature |
| Q39317999 | Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. |
| Q37098900 | Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression |
| Q36867626 | Using the Past to Inform the Future: Anti-VEGF Therapy as a Road Map to Develop Novel Therapies for Diabetic Retinopathy |
| Q47127846 | Utf1 contributes to intergenerational epigenetic inheritance of pluripotency |
| Q92229613 | VEGF in Signaling and Disease: Beyond Discovery and Development |
| Q50457028 | VEGF modulates synaptic activity in the developing spinal cord. |
| Q33573324 | VEGF targets the tumour cell |
| Q41961850 | VEGF-A isoform-specific regulation of calcium ion flux, transcriptional activation and endothelial cell migration |
| Q34081464 | VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions |
| Q37236916 | VEGF-A regulated by progesterone governs uterine angiogenesis and vascular remodelling during pregnancy. |
| Q37644376 | VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart. |
| Q34480730 | VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2-dependent Ca2+ signaling |
| Q64277092 | VEGF/Neuropilin Signaling in Cancer Stem Cells |
| Q42491822 | VEGFB/VEGFR1-Induced Expansion of Adipose Vasculature Counteracts Obesity and Related Metabolic Complications |
| Q38268530 | VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels. |
| Q33748993 | VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis |
| Q64954829 | Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching. |
| Q52719147 | Vascular Endothelial Growth Factor-A Exerts Diverse Cellular Effects via Small G Proteins, Rho and Rap. |
| Q36337071 | Vascular Notch proteins and Notch signaling in the peri-implantation mouse uterus |
| Q27003400 | Vascular endothelial growth factor-B in physiology and disease |
| Q38401902 | Vascularization strategies for tissue engineers |
| Q59329186 | Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues |
| Q52655088 | Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo. |
| Q91910450 | Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis |
| Q43007023 | YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation |
| Q52572356 | YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α. |
| Q38031707 | Zebrafish: an emerging model of vascular development and remodelling |
| Q36432885 | miR-1 and miR-206 regulate angiogenesis by modulating VegfA expression in zebrafish. |
| Q36060465 | miR-126 Regulation of Angiogenesis in Age-Related Macular Degeneration in CNV Mouse Model |
| Q35917632 | miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling |
Search more.